AAAnita Aperia

Anita Aperia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anita Aperia has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A missense mutation converts the Na+,K+-ATPase into an ion channel and causes therapy-resistant epilepsy

    by Sofia Ygberg, Evgeny E. Akkuratov, Rebecca J. Howard, Fulya Taylan, Daniel C. Jans, Dhani R. Mahato, Adriana Katz, Paula F. Kinoshita, Benjamin Portal, Inger Nennesmo, et al.


  • Open Access

    Variability in the strength of AT 1 R Ca 2+ signaling

    by Lena Scott, Kristoffer Bernhem, Hjalmar Brismar, Anita Aperia

    The renin angiotensin system is a principal physiological regulatory system for blood pressure and the Angiotensin type 1 receptor (AT 1 R) is an important target for treatment of hypertension. Using AT 1 R expressing HEK293a cells we study the Ca 2+ response to repeated doses of physiological, 1 nM [Ang II] and pharmacological, 100 nM [Ang II] at 0, 7 and 37 min. AT 1 R activation results in Ca 2+ release from intracellular stores. AT 1 R signaling has typically been studied at pharmacological 100 nM [Ang II]. At 100 nM [Ang II] a significant desensitization was seen in response to the 2nd dose with partial recovery observed at the 3rd dose. Mean Δ [Ca 2+ ] i was 150, 30 and 70 nM respectively. At 1 nM [Ang II] no desensitization was observed between the first two doses, both at 15 nM, and the response to the 3rd dose, 40 nM, is significantly increased. As recent studies suggest a crosstalk between AT 1 R and Voltage Gated Calcium Channels, we also studied the effect of blocking Ca 2+ channels with Nifedipine, therapeutically used in hypertension treatments, on AT 1 R response. No change to basal [Ca 2+ ] was seen in presence of Nifedipine, whilst an increase was found in Ca 2+ response from repeated doses of 1 nM [Ang II], 130, 110 and 80 nM. The same trend was seen in Podocyte enriched primary cultures. In summary this study shows novel aspects to the AT 1 R signaling modulation with implications for the treatment of hypertension.

  • Open Access

    OUABAIN RESCUES NEPHROGENESIS IN GROWTH‐FACTOR DEPRIVED EMBRYONIC RAT KIDNEY

    by Juan Li, Ilaria Perini, Markus Kruusmägi, Oleg Aizman, Sergey Zelenin, Anita Aperia

    Fetal malnutrition and other factors contributing to renal growth retardation result in increased apoptosis and reduction in nephron endowment. Our group has described a novel signaling pathway, where direct interaction between Na,K‐ATPase (NKA) and IP3R triggers slow calcium oscillations and activation of NFkappaB (PNAS 2001, JBC 2003, 2006). This signaling pathway is activated by ouabain, a specific ligand of NKA. Downstream effects include protection from apoptosis and stimulation of cell proliferation (JASN 2006). Here we report activation of this signaling pathway rescues nephrogenesis in growth factor deprived (gfd) embryonic rat kidney. Kidneys from E14 rats were cultured under normal or gfd conditions and studied after 2–3 days in vitro. Exposure to ouabain triggered calcium oscillation and activated NF‐kappaB. Growth factor deprivation retarded ureter branching and formation of new glomeruli and increased apoptotic index. Exposure to nM ouabain prevented these effects. The protective effects of ouabain were abolished by depletion of intracellular calcium stores and by inhibition of NF‐kappaB, underlining the importance of the NKA‐IP3R signaling pathway. The expression of Wt1 and Pax2, which are activated by NF‐kappaB, was increased in ouabain exposed gfd kidneys. Thus we have identified a novel mechanism by which kidney development can be protected under adverse intrauterine circumstances.

  • Intracellular sodium modulates the state of protein kinase C phosphorylation of rat proximal tubule Na+,K+‐ATPase

    by F. R. Ibarra, S. X. Jun Cheng, M. Agrén, L.‐B. Svensson, O. Aizman, A. Aperia

    The natriuretic hormone dopamine and the antinatriuretic hormone noradrenaline, acting on α‐adrenergic receptors, have been shown to bidirectionally modulate the activity of renal tubular Na+,K+‐adenosine triphosphate (ATPase). Here we have examined whether intracellular sodium concentration influences the effects of these bidirectional forces on the state of phosphorylation of Na+,K+‐ATPase. Proximal tubules dissected from rat kidney were incubated with dopamine or the α‐adrenergic agonist, oxymetazoline, and transiently permeabilized in a medium where sodium concentration ranged between 5 and 70 mM. The variations of sodium concentration in the medium had a proportional effect on intracellular sodium. Dopamine and protein kinase C (PKC) phosphorylate the catalytic subunit of rat Na+,K+‐ATPase on the Ser23 residue. The level of PKC induced Na+,K+‐ATPase phosphorylation was determined using an antibody that only recognizes Na+,K+‐ATPase, which is not phosphorylated on its PKC site. Under basal conditions Na+,K+‐ATPase was predominantly in its phosphorylated state. When intracellular sodium was increased, Na+,K+‐ATPase was predominantly in its dephosphorylated state. Phosphorylation of Na+,K+‐ATPase by dopamine was most pronounced when intracellular sodium was high, and dephosphorylation by oxymetazoline was most pronounced when intracellular sodium was low. The oxymetazoline effect was mimicked by the calcium ionophore A23187. An inhibitor of the calcium‐dependent protein phosphatase, calcineurin, increased the state of Na+,K+‐ATPase phosphorylation. The results imply that phosphorylation of renal Na+,K+‐ATPase activity is modulated by the level of intracellular sodium and that this effect involves PKC and calcium signalling pathways. The findings may have implication for the regulation of salt excretion and sodium homeostasis.


  • Neuropeptide Y shifts equilibrium between α- and β-adrenergic tonus in proximal tubule cells

    by Ulla Holtbäck, Yoshiyuki Ohtomo, Petter Förberg, Bo Sahlgren, Anita Aperia

    Renal sympathetic nerves play a central role in the regulation of tubular Na+reabsorption. Norepinephrine (NE) and neuropeptide Y (NPY) are colocalized in renal sympathetic nerve endings. The purpose of this study is to examine the integrated effects of these neurotransmitters on the regulation of Na+-K+-ATPase, the enzyme responsible for active Na+reabsorption in renal tubular cells. Studies were performed on proximal tubular segments, which express adrenergic α- and β-receptors, as well as NPY-Y2receptors. It was found that α- and β-adrenergic agonists had opposing effects on Na+-K+-ATPase activity. β-Adrenergic agonists induced a dose-dependent inhibition of the Na+-K+-ATPase activity, whereas α-adrenergic agonists stimulated the enzyme. NPY abolished β-agonist-induced deactivation of Na+-K+-ATPase and enhanced α-agonist-induced activation of Na+-K+-ATPase. The β-adrenergic agonist appeared to inhibit Na+-K+-ATPase activity via a cAMP pathway. NPY antagonized β-agonist-induced accumulation of cAMP. In our preparation, NE alone had no net effect but stimulated the Na+-K+-ATPase activity in the presence of β-adrenergic antagonists, as well as in the presence of NPY. The results indicate that, in renal tissue, NPY determines the net effect of its colocalized transmitter, NE, by its ability to attenuate the β- and enhance the α-adrenergic effect.


  • Development of urinary concentrating capacity: role of aquaporin-2

    by M. Yasui, D. Marples, R. Belusa, A. C. Eklof, G. Celsi, S. Nielsen, A. Aperia

    The capacity to concentrate urine develops progressively during postnatal life in most mammalian species. Here we have examined whether low expression of the arginine vasopressin (AVP)-activated water channel aquaporin-2 (AQP-2) may be a limiting factor for the concentrating capacity in the infant rats. Urine osmolality in response to 24-h dehydration increased significantly from 10 to 40 days of age. The most rapid increase occurred during the weaning period, i.e., days 15-20. A similar developmental pattern was observed for AQP-2 mRNA levels in the renal medulla. AQP-2 protein levels also increased markedly from day 10 to 40. Immunohistochemistry revealed that AQP-2 was exclusively located in collecting duct principal cells both in infant and adult rats but that the signal was much weaker in infants. To further examine the relationship between urinary concentrating capacity and AQP-2 expression, we treated rats with a single injection of betamethasone, which is known to accelerate maturation in several organs. Twenty-four hours after treatment, there was an increase in urine osmolality, renal medullary AQP-2 mRNA, and AQP-2 protein levels in infant but not in adult rats. A single injection of a specific V2 agonist caused within 6 h significant increase of AQP-2 mRNA in both infant and adult. The expression of the mRNA of three other transporters involved in the concentrating process, medullary Na(+)-K(+)-ATPase alpha-subunit, Na-K-2Cl cotransporter, and epithelial chloride channel also increased during the weaning period and were upregulated by glucocorticoids. We conclude that there is a well-synchronized development of the many of the components that determine the concentrating capacity and that the low expression of AQP-2 is one of the limiting factors for low concentrating capacity in infants.